Pfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has declined 34.61% YoY and -10.94% YTD due to COVID-19 revenue decrease. Technical analysis shows bearish trend with potential for further downside.

Related Keywords

, Pfizer Inc , Cantor Fitzgerald , Pfizer , Wall Street , Moving Average Convergence Divergence , Relative Strength Index , Bollinger Bands , Big Money , Consensus Estimates ,